Weiwei Huang

Pr
Xuancheng, 242000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Syncytium-forming HSV-1 in cancer gene therapy: From molecular mechanisms to clinical translation.

Syncytium-forming HSV-1 in cancer gene therapy: From molecular mechanisms to clinical translation.

Journal: Virulence

Published: September 04, 2026

Association between frailty and breast cancer incidence and construction of a breast cancer prediction model based on machine learning.

Association between frailty and breast cancer incidence and construction of a breast cancer prediction model based on machine learning.

Journal: Frontiers in public health

Published: April 17, 2026

Real-world outcomes and safety of inetetamab plus pyrotinib and chemotherapy in HER2-positive metastatic breast cancer: A multicenter retrospective study.

Real-world outcomes and safety of inetetamab plus pyrotinib and chemotherapy in HER2-positive metastatic breast cancer: A multicenter retrospective study.

Journal: Therapeutic advances in medical oncology

Published: March 18, 2026

Nab-paclitaxel inhibits angiogenesis via the CYR61/integrin αvβ3 Axis: Exosomal proteomics insights into breast cancer chemoprevention.

Nab-paclitaxel inhibits angiogenesis via the CYR61/integrin αvβ3 Axis: Exosomal proteomics insights into breast cancer chemoprevention.

Journal: Toxicology and applied pharmacology

Published: November 25, 2025

Cost-effectiveness analysis of inavolisib combined with palbociclib plus fulvestrant in PIK3CA-mutated HR+/Her2- advanced breast cancer in China.

Cost-effectiveness analysis of inavolisib combined with palbociclib plus fulvestrant in PIK3CA-mutated HR+/Her2- advanced breast cancer in China.

Journal: Frontiers in pharmacology

Published: November 09, 2025

Apatinib Mesylate in the Treatment of Advanced Triple-Negative Breast Cancer.

Apatinib Mesylate in the Treatment of Advanced Triple-Negative Breast Cancer.

Journal: Oncology research and treatment

Published: September 24, 2025

Multiomics Machine Learning to Predict Neoadjuvant Chemotherapy Outcome and Relapse of Breast Cancer.

Multiomics Machine Learning to Predict Neoadjuvant Chemotherapy Outcome and Relapse of Breast Cancer.

Journal: BME frontiers

Published: August 20, 2025

Correction: Analysis of prognostic factors and nomogram construction for postoperative survival of triple-negative breast cancer.

Correction: Analysis of prognostic factors and nomogram construction for postoperative survival of triple-negative breast cancer.

Journal: Frontiers in immunology

Published: July 23, 2025

Application and Progress of Antibody-Drug Conjugates (ADCs) in the Treatment of Metastatic Triple-Negative Breast Cancer.

Application and Progress of Antibody-Drug Conjugates (ADCs) in the Treatment of Metastatic Triple-Negative Breast Cancer.

Journal: Oncology and therapy

Published: July 02, 2025

CRISPR-Mediated Viral Gene Knock-In for Studying Viral-Host Interactions.

CRISPR-Mediated Viral Gene Knock-In for Studying Viral-Host Interactions.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: June 14, 2025

Analysis of prognostic factors and nomogram construction for postoperative survival of triple-negative breast cancer.

Analysis of prognostic factors and nomogram construction for postoperative survival of triple-negative breast cancer.

Journal: Frontiers in immunology

Published: January 16, 2025

EZH2 mutation is associated with the development of visceral metastasis by enhancing proliferation and invasion and inhibiting apoptosis in breast cancer cells.

EZH2 mutation is associated with the development of visceral metastasis by enhancing proliferation and invasion and inhibiting apoptosis in breast cancer cells.

Journal: BMC cancer

Published: June 09, 2024

Showing 1-12 of 28

Last Updated: 09/26/2026